We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Rocket Companies
RKT
$38.9B
| $229K | 0.03% |
+31,084
| New | +$268K |
|
1002
Tactile Systems Technology
TCMD
$665M
| $229K | 0.03% |
+31,390
| New | +$398K |
|
1003
AbbVie
ABBV
$435B
| $228K | 0.03% |
+1,491
| New | +$228K |
|
1004
John Wiley & Sons Class A
WLY
$2.66B
| $228K | 0.03% |
+4,781
| New | +$244K |
|
|
CVET
1005
DELISTED
Covetrus, Inc. Common Stock
CVET
| $228K | 0.03% |
+11,005
| New | +$196K |
|
1006
Core & Main
CNM
$8.71B
| $227K | 0.03% |
+10,181
| New | +$236K |
|
1007
Precision BioSciences
DTIL
$207M
| $227K | 0.03% |
4,740
+987
| +26% | +$57.9K |
|
1008
Oric Pharmaceuticals
ORIC
$1.4B
| $227K | 0.03% |
50,635
+8,128
| +19% | +$32.4K |
|
1009
Par Pacific Holdings
PARR
$3.32B
| $227K | 0.03% |
14,532
-39,839
| -73% | -$627K |
|
1010
UGI
UGI
$7.33B
| $227K | 0.03% |
+5,888
| New | +$228K |
|
|
YALA
1011
Yalla Group
YALA
$832M
| $227K | 0.03% |
+58,092
| New | +$228K |
|
|
CTLT
1012
DELISTED
CATALENT, INC.
CTLT
| $227K | 0.03% |
+2,119
| New | +$216K |
|
1013
Group 1 Automotive
GPI
$3.18B
| $226K | 0.03% |
+1,332
| New | +$232K |
|
1014
OrthoPediatrics
KIDS
$595M
| $226K | 0.03% |
5,242
-12,870
| -71% | -$589K |
|
1015
Apple
AAPL
$4.57T
| $225K | 0.03% |
+1,647
| New | +$249K |
|
1016
Neogen
NEOG
$2.5B
| $225K | 0.03% |
9,322
-3,086
| -25% | -$82.8K |
|
1017
Post Holdings
POST
$3.57B
| $225K | 0.03% |
+2,733
| New | +$212K |
|
1018
Ring Energy
REI
$339M
| $225K | 0.03% |
84,427
+55,946
| +196% | +$232K |
|
|
RYZ
1019
Ryerson Holding Corp
RYZ
$1.46B
| $225K | 0.03% |
10,591
-4,066
| -28% | -$127K |
|
|
TXNM
1020
TXNM Energy Inc
TXNM
$5.94B
| $225K | 0.03% |
+4,699
| New | +$220K |
|
1021
Intel
INTC
$513B
| $224K | 0.03% |
+5,994
| New | +$259K |
|
|
LAND
1022
Gladstone Land Corp
LAND
$360M
| $223K | 0.03% |
+10,076
| New | +$304K |
|
1023
DigitalOcean
DOCN
$14.6B
| $222K | 0.03% |
+5,376
| New | +$240K |
|
1024
Lear
LEA
$8.18B
| $222K | 0.03% |
+1,761
| New | +$232K |
|
1025
Syndax Pharmaceuticals
SNDX
$1.82B
| $222K | 0.03% |
11,542
-31,758
| -73% | -$529K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.